Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 2/20 | 0.44 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.42 |
| ▸ | P2RY2 | P41231 | 6/20 | 0.39 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.39 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.38 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2525333 | 0.84 | TYMP (0.47) | TYMPP2RY14P2RY2P2RY12P2RY6 | |
| SCHEMBL18034343 | 0.84 | TYMP (0.47) | TYMPP2RY14P2RY2P2RY12P2RY6 | |
| SCHEMBL2525335 | 0.84 | TYMP (0.47) | TYMPP2RY14P2RY2P2RY12P2RY6 | |
| SCHEMBL15993943 | 0.84 | TYMP (0.44) | TYMPP2RY14P2RY2P2RY12P2RY6 | |
| SCHEMBL15993940 | 0.84 | TYMP (0.44) | TYMPP2RY14P2RY2P2RY12P2RY6 | |
| SCHEMBL7553293 | 0.84 | TYMP (0.51) | TYMPP2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL6831398 | 0.84 | TYMP (0.51) | TYMPP2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL6831397 | 0.84 | TYMP (0.51) | TYMPP2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL4451613 | 0.84 | TYMP (0.51) | TYMPP2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL19549038 | 0.84 | TYMP (0.53) | TYMPP2RY14P2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547852-A2 | MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | Alnylam Pharmaceuticals, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| WO-2024006953-A2 | MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |